Although polymorphisms at codons 129 and 219 play an important role in susceptibility to sporadic CJD, patients with other polymorphisms in PRNP exhibited critical distinctions of clinical symptoms. This evidence concerns the gene PRNP and sporadic Creutzfeldt-Jakob disease.